share_log

Minim | 8-K: Current report

Minim | 8-K:重大事件

美股sec公告 ·  2023/12/29 00:00
Moomoo AI 已提取核心訊息
On December 28, 2023, Minim, Inc., a Delaware-incorporated company listed on the Nasdaq Capital Market under the trading symbol MINM, announced significant changes to its Board of Directors. The company expanded its Board from four to seven directors, electing Avraham Ben-Tzvi, Matthew C. McMurdo, and David E. Lazar as new directors. The expansion and appointments are part of the company's governance and strategic growth plans. Ben-Tzvi brings extensive legal expertise, having founded ABZ Law Office and served as Chief Legal Officer at Purple Biotech Ltd. McMurdo, with a background in corporate law, is the Managing Member of McMurdo Law Group, LLC, and has held various legal positions in the past. Lazar, the CEO of Titan Pharmaceuticals Inc. and...Show More
On December 28, 2023, Minim, Inc., a Delaware-incorporated company listed on the Nasdaq Capital Market under the trading symbol MINM, announced significant changes to its Board of Directors. The company expanded its Board from four to seven directors, electing Avraham Ben-Tzvi, Matthew C. McMurdo, and David E. Lazar as new directors. The expansion and appointments are part of the company's governance and strategic growth plans. Ben-Tzvi brings extensive legal expertise, having founded ABZ Law Office and served as Chief Legal Officer at Purple Biotech Ltd. McMurdo, with a background in corporate law, is the Managing Member of McMurdo Law Group, LLC, and has held various legal positions in the past. Lazar, the CEO of Titan Pharmaceuticals Inc. and Custodian Ventures LLC, offers a wealth of experience in financial and operations management. The new directors' terms will expire at Minim's 2024 annual meeting of stockholders. At the time of their election, none of the new directors were appointed to any Board committees. The Board has deemed Ben-Tzvi and McMurdo as independent directors, while Lazar, intended to be engaged as an executive officer, is not considered independent.
2023年12月28日,在納斯達克資本市場上市的特拉華州註冊公司Minim, Inc. 宣佈對董事會進行重大調整。該公司將董事會從四名董事擴大到七名,選舉阿夫拉姆·本-茨維、馬修·麥克默多和戴維·拉扎爾爲新董事。擴張和任命是公司治理和戰略增長計劃的一部分。Ben-Tzvi擁有豐富的法律專業知識,曾創立ABZ律師事務所,並在紫色生物技術有限公司擔任首席法務官。麥克默多具有公司法背景,是麥克默多律師集團有限責任公司的管理成員,過去曾擔任過各種法律職務。泰坦製藥公司和Custodian Ventures LLC的首席執行官拉扎爾在財務和運營管理方面擁有豐富的經驗。新董事的任期將在Minim的2024年年度股東大會上到期。在他們當選時,沒有一位新董事被任命爲任何董事會委員會的成員。董事會已將Ben-Tzvi和McMurdo視爲獨立董事,而打算擔任執行官的拉扎爾不被視爲獨立董事。
2023年12月28日,在納斯達克資本市場上市的特拉華州註冊公司Minim, Inc. 宣佈對董事會進行重大調整。該公司將董事會從四名董事擴大到七名,選舉阿夫拉姆·本-茨維、馬修·麥克默多和戴維·拉扎爾爲新董事。擴張和任命是公司治理和戰略增長計劃的一部分。Ben-Tzvi擁有豐富的法律專業知識,曾創立ABZ律師事務所,並在紫色生物技術有限公司擔任首席法務官。麥克默多具有公司法背景,是麥克默多律師集團有限責任公司的管理成員,過去曾擔任過各種法律職務。泰坦製藥公司和Custodian Ventures LLC的首席執行官拉扎爾在財務和運營管理方面擁有豐富的經驗。新董事的任期將在Minim的2024年年度股東大會上到期。在他們當選時,沒有一位新董事被任命爲任何董事會委員會的成員。董事會已將Ben-Tzvi和McMurdo視爲獨立董事,而打算擔任執行官的拉扎爾不被視爲獨立董事。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息